Search results
Results From The WOW.Com Content Network
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from a somatic cell. The iPSC technology was pioneered by Shinya Yamanaka and Kazutoshi Takahashi in Kyoto, Japan, who together showed in 2006 that the introduction of four specific genes (named Myc, Oct3/4, Sox2 ...
Plant stem cells are innately undifferentiated cells located in the meristems of plants. [ 1] Plant stem cells serve as the origin of plant vitality, as they maintain themselves while providing a steady supply of precursor cells to form differentiated tissues and organs in plants. [ 2][failed verification] Two distinct areas of stem cells are ...
Stem cell tourism is the part of the medical tourism industry in which patients travel to obtain stem cell procedures. [110] The United States has had an explosion of "stem cell clinics". [111] Stem cell procedures are highly profitable for clinics. The advertising sounds authoritative but the efficacy and safety of the procedures is unproven.
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated ( ACT ), which was renamed to Ocata Therapeutics in November 2014 ...
Legalization and funding. S1909/A2840 is a bill that was passed by the New Jersey legislature in December 2003, and signed into law by Governor James McGreevey on January 4, 2004, that permits human cloning for the purpose of developing and harvesting human stem cells.
A peer company, StemCells, emerged in 1995 in California with a focus on neural regeneration, but using stem cell technology emerging from the laboratory of Irving Weissman at Stanford University. [3] The year 1997 saw the start of a multi-million dollar research and licensing arrangement with Novartis, which initially acquired 8% of the ...
StemCell Technologies Canada Inc. (formerly known as StemCell Technologies Inc.) is a Canadian biotechnology company that develops and manufactures cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research. [ 1][ 2] The company has offices in the United States, Europe, Asia, and Australia with the ...
Neuralstem Inc. is a biotechnology company headquartered in Rockville, Maryland that specializes in developing commercial-scale production of multiple types of central nervous system stem cells. [1] In October 2019 Neuralstem announces that the company has changed its name to Seneca Biopharma, Inc. [2] In April 2021 Seneca Biopharma merged with ...